Progyny, Inc. (PGNY)
35.81
+0.97
(+2.78%)
USD |
NASDAQ |
Nov 09, 13:25
Progyny Shareholders Equity (Quarterly) : 414.03M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 414.03M |
| June 30, 2026 | 453.26M |
| March 31, 2026 | 439.34M |
| December 31, 2025 | 516.04M |
| September 30, 2025 | 560.00M |
| June 30, 2025 | 515.02M |
| March 31, 2025 | 467.16M |
| December 31, 2024 | 422.06M |
| September 30, 2024 | 434.88M |
| June 30, 2024 | 456.19M |
| March 31, 2024 | 571.60M |
| December 31, 2023 | 553.43M |
| September 30, 2023 | 515.39M |
| June 30, 2023 | 469.50M |
| March 31, 2023 | 424.40M |
| December 31, 2022 | 376.97M |
| Date | Value |
|---|---|
| September 30, 2022 | 346.86M |
| June 30, 2022 | 311.02M |
| March 31, 2022 | 279.62M |
| December 31, 2021 | 251.82M |
| September 30, 2021 | 224.11M |
| June 30, 2021 | 204.54M |
| March 31, 2021 | 184.62M |
| December 31, 2020 | 166.95M |
| September 30, 2020 | 127.27M |
| June 30, 2020 | 119.56M |
| March 31, 2020 | 121.09M |
| December 31, 2019 | 114.27M |
| September 30, 2019 | -91.25M |
| June 30, 2019 | -89.51M |
| March 31, 2019 | -92.08M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DaVita, Inc. | -591.09M |
| Acadia Healthcare Co., Inc. | 2.022B |
| U.S. Physical Therapy, Inc. | 429.30M |
| Lifestance Health Group, Inc. | 1.492B |
| Concentra Group Holdings Parent, Inc. | 506.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 675.79M |
| Total Liabilities (Quarterly) | 261.76M |
| Debt to Equity Ratio | 0.0625 |
| Current Ratio | 1.935 |
| Net Debt Paydown Yield | 0.03% |